Freespira: A Digital Therapeutic Gains Reimbursement for an Expensive Condition

article image
ARTICLE SUMMARY:

Palo Alto Health Sciences has a digital therapeutic without a drug component. Once it surmounted the challenge of FDA clearance, if faced perhaps a bigger hurdle: reimbursement. The company did a study focused on the economic benefits of its solution, and gained reimbursement from one of the largest Blue Cross Blue Shield-affiliated insurers.

Maybe it’s because Palo Alto Health Sciences Inc. was in the right place at the right time, or perhaps it just picked the right claim for encouraging market adoption, but the company’s Freespira therapy for certain anxiety disorders is the rare non-drug digital therapy with reimbursement from a major commercial health insurer.

×



This article is restricted to subscribers only.

Sign in to continue reading.

Questions?

We're here to help! Please contact us at: